Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Priority Brief

Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial

Shihong Zhang, Karan Kohli, R. Graeme Black, Lu Yao, Sydney M. Spadinger, Qianchuan He, Venu G. Pillarisetty, Lee D. Cranmer, Brian A. Van Tine, Cassian Yee, Robert H. Pierce, Stanley R. Riddell, Robin L. Jones and Seth M. Pollack
Shihong Zhang
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karan Kohli
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Graeme Black
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lu Yao
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sydney M. Spadinger
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sydney M. Spadinger
Qianchuan He
2Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Venu G. Pillarisetty
3Department of Surgery, University of Washington, Seattle, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Venu G. Pillarisetty
Lee D. Cranmer
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
4Division of Medical Oncology, University of Washington, Seattle, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian A. Van Tine
5Division of Oncology, Washington University in St. Louis, St. Louis, Missouri.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brian A. Van Tine
Cassian Yee
6Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cassian Yee
Robert H. Pierce
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert H. Pierce
Stanley R. Riddell
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
4Division of Medical Oncology, University of Washington, Seattle, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robin L. Jones
7Sarcoma Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seth M. Pollack
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
4Division of Medical Oncology, University of Washington, Seattle, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: spollack@fredhutch.org
DOI: 10.1158/2326-6066.CIR-18-0940 Published August 2019
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: June 2019 to January 2021

AbstractFull-text HTMLPDF
Total176327071768

Cited By

Article Information

Volume 7, Issue 8, pp. 1237-1243

DOI 
https://doi.org/10.1158/2326-6066.CIR-18-0940
PubMed 
31171504

Published By 
American Association for Cancer Research
Print ISSN 
2326-6066
Online ISSN 
2326-6074
History 
  • Received January 3, 2019
  • Revision received March 9, 2019
  • Accepted June 3, 2019
  • Published first June 6, 2019.

Article Versions

  • Previous version (June 6, 2019 - 06:46).
  • Previous version (June 25, 2019 - 06:46).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2019 American Association for Cancer Research.

Author Information

  1. Shihong Zhang1,
  2. Karan Kohli1,
  3. R. Graeme Black1,
  4. Lu Yao1,
  5. Sydney M. Spadinger1,
  6. Qianchuan He2,
  7. Venu G. Pillarisetty3,
  8. Lee D. Cranmer1,4,
  9. Brian A. Van Tine5,
  10. Cassian Yee6,
  11. Robert H. Pierce1,
  12. Stanley R. Riddell1,4,
  13. Robin L. Jones7, and
  14. Seth M. Pollack1,4,*
  1. 1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  2. 2Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  3. 3Department of Surgery, University of Washington, Seattle, Washington.
  4. 4Division of Medical Oncology, University of Washington, Seattle, Washington.
  5. 5Division of Oncology, Washington University in St. Louis, St. Louis, Missouri.
  6. 6Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  7. 7Sarcoma Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK.
  1. ↵*Corresponding Author:
    Seth M. Pollack, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D3-100, Seattle, WA 98109. Phone: 206-667-6629; E-mail: spollack{at}fredhutch.org
View Full Text
PreviousNext
Back to top
Cancer Immunology Research: 7 (8)
August 2019
Volume 7, Issue 8
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial
Shihong Zhang, Karan Kohli, R. Graeme Black, Lu Yao, Sydney M. Spadinger, Qianchuan He, Venu G. Pillarisetty, Lee D. Cranmer, Brian A. Van Tine, Cassian Yee, Robert H. Pierce, Stanley R. Riddell, Robin L. Jones and Seth M. Pollack
Cancer Immunol Res August 1 2019 (7) (8) 1237-1243; DOI: 10.1158/2326-6066.CIR-18-0940

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial
Shihong Zhang, Karan Kohli, R. Graeme Black, Lu Yao, Sydney M. Spadinger, Qianchuan He, Venu G. Pillarisetty, Lee D. Cranmer, Brian A. Van Tine, Cassian Yee, Robert H. Pierce, Stanley R. Riddell, Robin L. Jones and Seth M. Pollack
Cancer Immunol Res August 1 2019 (7) (8) 1237-1243; DOI: 10.1158/2326-6066.CIR-18-0940
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • CD47–SIRPα Checkpoint Controls CD18 Activation via Kindlin3
  • Triple Therapy Depletes Immune-Potentiating Myeloid Cells
  • Inducing CTLs through DLnano-vaccines to Target Cancer
Show more Priority Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement